During the pandemic, the rapid use of contactless technology resulted in faster, simpler, and more seamless services. According to Thomas Grellner, CEO of German MedTech firm Smedo, this innovation may also be injected into the healthcare industry to streamline operations and save lives.
According to rellner, patients in critical care units are presently monitored by a variety of complicated electrocardiogram (ECG) gadgets that capture a patient’s cardiac activity. While these instruments are efficient, they are costly, with prices ranging from $1,800 to $2,500 per device.
According to rellner, patients in critical care units are presently monitored by a variety of complicated electrocardiogram (ECG) gadgets that capture a patient’s cardiac activity. While these instruments are efficient, they are costly, with prices ranging from $1,800 to $2,500 per device.
The gadget, which can capture data from up to seven meters away, may continually record patients’ vital signs, such as heart rate, breathing, blood pressure, and temperature, monitoring data from not just one, but multiple people in a room in real-time.
He claims that by employing a high-frequency band, the wave-emitting gadget is not toxic and poses no health concerns to patients or medical employees who may subsequently evaluate the collected data.
Last month, the Berlin-based business announced the completion of a seed fundraising round of around €2 million ($2.1 million), which would be used to develop and promote the contactless gadget in hospitals and nursing homes across the country.
